Catalyst Biosciences Sponsored Study Titled ‘Screening Study to Identify Patients With Complement Factor I Deficiencies’ Posted To ClinicalTrials.Gov; Study Not Yet Recruiting

https://clinicaltrials.gov/ct2/show/NCT05072912

byBenzinga Newsdesk

October 11, 2021

1 minute read

https://clinicaltrials.gov/ct2/show/NCT05072912

Cathie Wood Makes Massive Buy In Nvidia Stock: Here’s What You Should Know

By Bhavik Nair

Today, 6:45 PM

Cathie Wood-led Ark Investment Management on Monday bought 366,982 shares of NVIDIA Corporation (NASDAQ: NVDA) valued at nearly $65.3 million, based on Monday’s closing price, via three of its exchange-traded funds.

ARKF

Microsoft And Apple Lead The Dow Jones Higher Friday

By Henry Khederian

Today, 6:45 PM

U.S. indices were trading higher Friday following better-than-expected jobless claims, which lifted recovery sentiment to start off July.

AAPL

Tesla Stock Pops On Elon Musk Comments: What’s Going On?

By Adam Eckert

Today, 6:45 PM

Tesla Inc (NASDAQ: TSLA) shares are trading higher in Thursday's after-hours session following CEO Elon Musk's statement that he would refrain from selling any Tesla stock in 2023. Musk also suggested that a buyback could be coming next year.

TSLA

S&P 500 Circles New 2022 Lows Following Latest Fed Rate Hike: Is A Recession Inevitable?

By Wayne Duggan

Today, 6:45 PM

The SPDR S&P 500 ETF Trust (NYSE: SPY) suffered more heavy losses this week in response to another aggressive Federal Reserve interest rate hike

ACB

Catalyst Biosciences Sponsored Study Titled ‘Screening Study to Identify Patients With Complement Factor I Deficiencies’ Posted To ClinicalTrials.Gov; Study Not Yet Recruiting

Related Posts

Cathie Wood Makes Massive Buy In Nvidia Stock: Here’s What You Should Know

Microsoft And Apple Lead The Dow Jones Higher Friday

Tesla Stock Pops On Elon Musk Comments: What’s Going On?

S&P 500 Circles New 2022 Lows Following Latest Fed Rate Hike: Is A Recession Inevitable?